Ann: Theranostic prostate cancer trial advances to cohort 3, page-51

There are soooo many ways to value a company.
The idea that Clarity will be aggressively taken on in the share-market is not going to happen. US companies as i understand it cannot and Clarity was purposely floated in Aust for that reason.
There are not enough sellers who hold that they are going to sell, even if it hits $4. Some script will change hands but big funds coming in are going to want more than that.

Clarity's valuation has to be considered as a plug and play. Selling to big pharma. There are few players in radiopharmaceuticals, and there are a number of obvious huge pharma companies not in this space currently. Pfizer and J&J are two not in it. Goggle top 20 Radiopharma companies. DYR and it stands out.
Big pharma wants income streams into the future, like 2028 onwards (Pfizer aquisition of Seagen). These companies know everything about Clarity.

If you believe in this tech, get in. If you're not sure wait and see. I believe in this tech, and certainly do not think any of the major players would want to miss out on buying this company. I also think there could be block plays. It is just a when and how much. As has been said by a number of bloggers, they must continue to deliver data data. Faster faster and faster. It is amazing what they are doing with say 50 staff.

And yes they have some skilled people playing their hand at M&A in the background, outside the board.

Simply wall st is an interesting look. They value CU6 higher than Telix. A lot higher. if you believe that stuff.

Just opinions. Nothing serious. DYR and enjoy the banter.